🇺🇸 FDA
Patent

US 10952970

Use of vitelline protein B as a microencapsulating additive

granted A61KA61K2039/542A61K2039/575

Quick answer

US patent 10952970 (Use of vitelline protein B as a microencapsulating additive) held by The Regents of the University of California expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/542, A61K2039/575, A61K2039/6031, A61K38/17